Scientific evidence supports the positive role of physical activity in the management of migraine.
Cognitive strategies to enhance headache sufferers’ ability to engage in behaviors that enhance their self-management of headaches.
You may already know that migraine disease is more common than Alzheimer’s disease, Parkinson’s disease, epilepsy and multiple sclerosis combined. And despite that fact, it receives a small fraction of the available neuroscience research funding. Not surprisingly there are a very small number of neuroscience researchers who decide to take on migraine as a project, or devote a laboratory or professional
June 2017 marks National Migraine Awareness Month (#MHAM). This month long series of events promotes education, collaboration and general consciousness enhancing regarding the neurological affliction, migraine disease. Enormous strides have been made over the last several years. Possibly 2017 will be the most significant year to date, since the advent of triptans in 1991, in the history of migraine
This February witnessed the tenth anniversary of “Headache on the Hill”, the highly successful annual advocacy event, sponsored by the Alliance for Headache Disorders Advocacy (AHDA), designed to draw attention to the need for increased funding for migraines and related headache disorders. Apart from being the tenth consecutive advocacy year, this year was also remarkable for another reason: the passage
“Epilepsy is more than a seizure. It’s a life changing and threatening condition affecting the person and their families terribly.” (Julie Clark, Scotland, UK, 2017) We can easily substitute migraine and headache into that quote . The result would be a commonly acknowledged expression assigned to migraine disease: Migraine is more than a headache… which is also life changing and affects people’s lives terribly. Coincidence? Probably not. It brings us to
The Vestibular Migraine Mystery The medical community is just now waking up to the high prevalence of vestibular migraine (VM). Current estimates vary but VM appears to affect up to 1- 3% of the general population. 10% of all migraineurs may suffer from VM. And more than 50% of people complaining of dizziness have VM. We are talking about
The last few years has seen a groundswell of promising research and innovative medications and devices designed to prevent or abort a migraine episode. The Association of Migraine Disorders reports on what we believe to be credible research and treatments that will withstand rigorous testing. When AMD refers to “novel approaches” we do not mean two minute YouTube guided imagery
A breakthrough year indeed! With CGRP antibodies leading the charge. It has been over a year since we reported on the great promise of CGRP antibodies and the immense promise they hold for a true, scientifically validated, migraine prevention medication. Our Twitter postings, for those that follow us, have kept pace with the developments, but it seems an opportune
“Merriam-Webster” definition of disability: “a physical, mental, cognitive, or developmental condition that impairs, interferes with, or limits a person’s ability to engage in certain tasks or actions or participate in typical daily activities and interactions” Controversy surrounds the question of whether or not migraine disease, in any or all of its manifestations, rises to the level of a disability.
The last year has been one of enormous promise for the prevention and treatment of migraine disease. Vigorous clinical trials of CGRP antibodies being aggressively pursued by Big Pharma, groundbreaking genetics research, and new developments in the area of neuromodulation have all led a renowned migraine expert, Dr. David Dodick, Chair of the American Migraine Foundation, to declare “2017 will be
There are several reasons we are re-visiting this subject, the focus of a newsletter 8 months ago. First, recent tweets on this subject have shown an enormous interest in this oft misunderstood area of the migraine spectrum. Second, a recent study on medications for childhood migraine called into question their efficacy. Specifically, placebo was shown to be as effective as
If you follow our Twitter postings with any degree of regularity you may recognize many of the devices/procedures summarized here. It was the recent release of the Cefaly II device that caused me to think that our followers deserved an up-to-date look at the devices available, especially if one was looking to add it to their treatment regimen. Migraine treatment